PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01350128 · COMPLETED
Trial details
- NCT number
- NCT01350128
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.